[Cardiology. Heart failure, cardiac imaging, congenital heart diseases, and cardio-oncology].

The year 2024 has seen significant progress in the management of heart failure. New treatments have demonstrated their efficacy, particularly for heart failure with preserved ejection fraction, cardiac amyloidosis, and hypertrophic cardiomyopathy. Advances in imaging, such as MRI and PET-CT, highlight the growing integration of innovative technologies and artificial intelligence in cardiology for diagnosing complex cardiovascular diseases. In the field of adult congenital heart disease, SGLT2 inhibitors show promising results in heart failure treatment, and percutaneous techniques have yielded positive outcomes. In cardio-oncology, new studies have focused on the prevention and management of cancer therapy-related cardiac dysfunction.